Objective. To present the incidence and prevalence of diabetes mellitus in the Americas
centage will have reached 62%, representing 40 million persons (1) . This increase results from multiple factors involved in lifestyle changes related to modern life such as the decrease in physical activities and the predominance of hypercaloric diets and the resulting obesity. Also playing a major part is the aging process of the population in developing countries. Given these various factors, an increase in diabetes mellitus caseload will be more evident in developing countries.
Diabetes increases the risk of premature death mainly due to an increased risk of cardiovascular events. In addition, people suffering from diabetes have a greater risk of developing visual problems and renal disease as well as undergoing lower-extremity amputations.
Diagnostic criteria and classification
In 1985 the World Health Organization (WHO) published updated criteria for the diagnosis of diabetes mellitus (2) . More recently, in 1997, the American Diabetes Association (ADA) published new diagnostic criteria lowering the fasting plasma glucose concentration for the diagnosis of the disease from ≥ 140 mg/dL to ≥ 126 mg/ dL. WHO published similar criteria for the diagnosis of diabetes in 1999 after a WHO expert committee reviewed the issue and reached the same conclusions as the ADA (3, 4) . A new cutoff point for plasma glucose concentration 2 hours after an oral dose of 75 mg of glucose was established because of the proven increase in the prevalence of diabetes-related microvascular com-plications (e.g., retinopathy and nephropathy) among people with values of ≥ 200 mg/dL. The previous fasting glucose cutoff point of 140 mg/dL identified subjects with more severe hyperglycemia than the present 2-hour cutoff point of 200 mg/dL. Thus, by lowering the fasting cutoff point to 126 mg/dL, it becomes possible to identify subjects whose hyperglycemia is roughly equivalent to that of subjects who test positive on the 2-hour glucose tolerance test.
In addition, in 2000 the ADA recommended using a fasting plasma glucose of ≥ 126 mg/dL as the sole criterion for diagnosing diabetes in epidemiologic studies (5) . However, WHO still recommends the 2-hour oral glucose tolerance test (OGTT) as the single best diagnostic criterion for such studies, but if this test cannot be performed because of logistic or economic reasons, the fasting plasma glucose alone, as established by the ADA, may be used instead as the basis for the diagnosis (4). According to the updated WHO classification of diabetes, there are two major forms of the disease: type 1 and type 2 (formerly, respectively, insulin-dependent diabetes mellitus (IDDM) and non-insulin dependent diabetes mellitus (NIDDM)). Type 1 diabetes appears mainly in children and young adults, is characterized by an acute onset, and requires insulin treatment. Type 2 diabetes appears insidiously, mainly in adults, and can be treated in a variety of ways, including with a dietary regimen, oral hypoglycemic agents, insulin, or a combination of these. Type 2 diabetes is the most common form of the disease, accounting for about 85% to 90% of all cases. It has been linked to potentially modifiable risk factors such as obesity, lack of exercise, and a hypercaloric diet. As many studies have demonstrated, in most populations there are many people with undiagnosed type 2 diabetes (6) (7) (8) . Another important subcategory under type 2 of the disease is gestational diabetes, which is defined as glucose intolerance (of any degree) diagnosed for the first time during pregnancy (9) . It is estimated that about 4% of pregnant women develop this form of diabetes.
The objective of this paper is to present the incidence and prevalence of diabetes mellitus in the Americas as found through a comprehensive review of published information on the subject.
MATERIALS AND METHODS
We conducted a comprehensive literature search to identify results from apparently unbiased populationbased diabetes surveys and registries. The search was conducted using the MEDLINE and BIREME bibliographic databases. The terms used in the search were "diabetes incidence," "diabetes prevalence," "diabetes survey," and "diabetes registry." Literature that was not indexed, such as gray papers, government publications, and conference proceedings, was obtained by contacting government offices, nongovernmental organizations, scientific and diabetes associations, and the country offices of the Pan American Health Organization (PAHO). Incidence and prevalence rates were adjusted by age and sex, when possible, by the direct method, using the world Segi population as the standard (10) . The 95% confidence intervals (95% CIs) were calculated using the Poisson distribution or the normal distribution, as described by King et al. (11) . Published articles including diabetes estimates and projections were also reviewed.
RESULTS

Incidence and prevalence of childhood diabetes
The worldwide incidence of type 1 diabetes has been evaluated during the last 20 years through the DiaMond Project (12) (13) (14) , which oversees the maintenance of registries of children with diabetes around the world. About 24 of these registries operate in the Region of the Americas. There have been other publications in the Region on the incidence of type 1 diabetes, mainly in children under 15 years of age. Since most registries rely on more than one source of information, we assessed their completeness. The subsections below summarize the data for the specific subregions and countries of the Americas, with 15 .0 per 100 000), and Chicago, Illinois (incidence of 11.7 per 100 000 population). A registry in Rochester, Minnesota, reported a childhood incidence rate of 20.8 per 100 000 in 1980 (14) .
Caribbean. In the Caribbean, the estimated prevalence rate of type 1 diabetes in children under 15 years of age ranged from 6.4 per 10 000 in Puerto Rico to 0.3 per 10 000 in Haiti in 1997 (Table 1) . A high incidence rate has been consistently reported by Puerto Rico (19) . The lowest childhood incidence in the Caribbean was reported for Barbados.
Antigua, Barbados, Dominica, Saint. Croix, Saint Thomas, and Tortola Island reported on the incidence of type 1 diabetes among those aged 0 to 19 years. The highest incidence rate was reported for Saint Croix, and the lowest was reported for Saint Kitts (20) .
Central America. The estimated prevalence of type 1 diabetes among chil-dren under the age of 15 years ranged from 1.1 per 10 000 population in Panama to 0.4 per 10 000 in Guatemala and Honduras in 1997 (Table 1) .
South America. In South America in 1997, 31 000 children under 15 years of age were estimated to have type 1 diabetes (15). The greatest prevalence was estimated for Uruguay (4.9 per 10 000), while the lowest was estimated for Peru (0.4 per 10 000) ( Table  1 ). The highest incidence of type 1 diabetes among children was also reported in Uruguay (8.3 per 100 000), while the lowest was reported in Venezuela (0.1 per 100 000). Tierra del Fuego, Argentina, reported an incidence rate of 20.2 per 100 000 among boys, but this rate was based on only 4 cases, and no case was reported among girls, for a total incidence of 8.0 per 100 000 for both sexes. In the Americas, only the Colombian registry reported statistically significant differences between boys and girls (4.7 vs. 2.9 per 100 000, respectively).
Diabetes in adult populations
Most countries in Latin America and the Caribbean do not carry out epidemiological surveillance for diabetes in adults. Therefore, information on the prevalence of this type of diabetes in those nations is limited. Some surveys have been conducted but not usually as part of national or regional policies for diabetes surveillance. Accordingly, surveys of diabetes carried out in Latin America and the Caribbean have been sporadic, and they differ in important methodological features such as selection of the study population, age, sampling method, and diagnostic criteria. For this reason, comparison between studies is often problematic. Nevertheless, diabetes surveys provide the only data available on the epidemiology of this disease. The characteristics of the diabetes surveys conducted in the Americas are shown in Table 2 . Most of the selected studies used the oral glucose tolerance test (OGTT) as a diagnostic test along with the WHO 1985 diagnostic criteria (2) . The largest survey conducted in the Americas, which in- 
South America. No published reports were found showing results of glucose tolerance tests in Ecuador and
Guyana. Among the surveys using OGTT and the WHO diagnostic criteria, the highest crude prevalence rate of diabetes was reported among Japanese immigrants to Brazil (Issei (second generation), 16.2%; Nisei (first generation), 12.6%). The adjusted prevalence rate for East Indians in Suriname (12.7%) was the highest in South America, but this study used an oral glucose load of 50 g for the 2-hour test and a cutoff blood glucose value of 180 mg/dL. Most South American studies reported diabetes prevalence rates of between 6% and 9%. The lowest crude prevalence rate was reported for the Aymara Indians in Chile (1.5%). The Mapuche Indians from Chile showed a low prevalence rate (1.0%) in 1985, but a more recent survey reported a prevalence rate of 4.1% in this group. A study conducted in Uruguay and Venezuela in 1966, using an oral load of 1 g of glucose per kg of body weight and a cutoff point of 150 mg/dL, reported prevalence rates of 6.9% and 7.3% for these countries, respectively.
Adjusted prevalence rates among subjects aged 35 to 64 years
Among people 35 to 64 years old, in the countries for which data were available, the prevalence of diabetes was highest in Jamaica (15.6%) (Table  4) . Mexico, Trinidad and Tobago, and Bolivia also presented prevalence rates over 10%. Moderate prevalence rates (3%-10%) were observed in the rest of the countries. The lowest prevalence rate was observed in La Plata, Argentina (3.0%). Jamaican, Mexican, and Chilean males had prevalence rates of over 10%. Moderate prevalence rates for diabetes were observed in males from the rest of the countries. Women were at higher risk in Jamaica, Mexico, Trinidad and Tobago, and Bolivia, while Brazilian, Colombian, Paraguayan, and Surinamese women had moderate prevalence rates (3%-9%). Argentine women presented the lowest prevalence rate (2.6%).
DISCUSSION
As evidenced by the data presented in this article, in some areas of the Americas there is a pronounced lack of information regarding diabetes. Nonetheless, it is obvious that diabetes represents a major public health problem for the Americas, and there is evidence that its prevalence is increasing (33, 46) . Given that most Latin American and Caribbean countries are experiencing a demographic transition, the prevalence of diabetes is expected to increase rapidly in the near future.
We found great variability in the incidence of type 1 diabetes in the Americas, ranging from 24 per 100 000 in some areas of Canada in 1990-1993 to 0.2 per 100 000 in Venezuela in 1992. In 1997, the prevalence of type 1 diabetes among persons under 15 years of age in the Americas was estimated at 88 000. Of these children, 35 000 (40%) lived in Latin America and the Caribbean. Although type 1 diabetes appears to be uncommon in most Latin American and Caribbean (LAC) countries, the increased related mortality and disability among young adults make this disease a considerable burden to society (54) (55) (56) (57) . Public health actions to ensure access to quality care in this population are urgently needed. Although type 2 diabetes appears with more frequency in people over 40 years of age, there are reports showing a growing prevalence of this clinical type among children in various segments of the United States population (58) (59) (60) (61) . It is not clear whether this phenomenon is already occurring in LAC, but it is anticipated that a similar trend will emerge unless prevention strategies are introduced in the LAC nations.
Of special note are the prevalence rates of diabetes mellitus observed among native American populations and other ethnic and minority groups in the various countries of the Americas. In the state of Arizona in the United States, more than half of the adult Pima Indians are known to have diabetes, and other Native Americans from the United States and Canada also have an increased prevalence of diabetes. Other ethnic and minority groups in the United States, such as Mexican-Americans and non-Hispanic blacks, are also disproportionately affected by diabetes (28) .
In most urban populations of Latin America and the Caribbean, the prevalence of diabetes among adults is between 6% and 8%. While the Mapuche Indians of Chile were practically free of diabetes in 1985, they showed prevalence rates of 3.2% among males and 4.5% among females in 2000. These results suggest that an acculturation process, with the predominance of a lack of physical activity and a hypercaloric diet, may be occurring in this native community, and the same process may be occurring across Latin America.
It is evident from the results of various surveys in LAC that diabetes is particularly affecting people from the lower socioeconomic classes, as evidenced by higher prevalence rates for people with lower educational levels in Bolivia (8) and in Jamaica (6) . This may be because of higher exposure to major risk factors such as hypercaloric diet, low physical activity, and obesity.
According to new evidence from the Finnish Diabetes Prevention Study (62) and elsewhere, more than half of the diabetes cases can be prevented among those at higher risk. Diabetes prevention and control programs are urgently needed and are potentially cost-effective strategies that can reduce the huge burden of diabetes (63) . Disease control programs should address the comparatively higher prevalence of diabetes reported among women, the less educated, and low-income populations in the Americas. Despite economic constraints, there is a clear need for intervention. A coordinated action plan to deal with the current epidemic of diabetes is critical in order to take the available technological advances in the field of diabetes prevention and control and to translate them into affordable public health actions.
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